Summit Global Investments »

Cytek Biosciences shares owned by Summit Global Investments

Quarter-by-quarter ownership of Cytek Biosciences (CTKB) shares owned by Summit Global Investments from 13F filings

Historical chart of Summit Global Investments investment in Cytek Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cytek Biosciences held by Summit Global Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytek Biosciences by Summit Global Investments

Quarter filed Position value Share count Share price at filing
2025-03-31 $220k 55k 4.01
2024-12-31 $235k 36k 6.49

More positions owned by Summit Global Investments

RBB Sgi Enhanced Cor (USDX)
RBB Sgi Enhanced Mkt (LDRX)
RBB Sgi Us Large Cap (SGLC)
RBB Sgi Enhanced Glb (GINX)
RBB Sgi Diversi Tac (DYTA)
Ishares Tr Core Us Aggbd Et (AGG)
RBB Sgi Enhanced Nas (QXQ)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Microsoft Corporation (MSFT)
Apple (AAPL)
Pepsi (PEP)
Tesla Motors (TSLA)
Colgate-Palmolive Company (CL)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
Meta Platforms Cl A (META)

View all positions for Summit Global Investments

Top funds holding Cytek Biosciences

BlackRock
Vanguard Group
Hillhouse Capital Advisors
Brown Capital Management
State Street Corporation
Millennium Management
Dimensional Fund Advisors
Geode Capital Management
Wellington Management Company
Royce & Associates
Goldman Sachs Group
Morgan Stanley
Charles Schwab Investment Management
AQR Capital Management
Northern Trust

View all funds holding Cytek Biosciences